Evidence map›Paper›PMID 24866374›Full record

ArticleBioconjugate chemistry2014

Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.

Eun J Kim, Lara K Abramowitz, Michelle R Bond, Dona C Love, Dong W Kang, Hans F Leucke, Dae W Kang, Jong-Seog Ahn, John A Hanover

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Cells · 2022
    Review
  4. Chronically ElevatedFrontiers in immunology · 2022
    Article
  5. Article
  6. Overview of the Assays to ProbeMolecules (Basel, Switzerland) · 2021
    Review
  7. cat-ELCCA: catalyzing drug discovery through click chemistry.Chemical communications (Cambridge, England) · 2018
    Article
  8. O-GlcNAc-ylation in the Nuclear Pore Complex.Cellular and molecular bioengineering · 2016
    Article
  9. Article
  10. Chemical tools to explore nutrient-driven O-GlcNAc cycling.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eun J KimDepartment of Science Education-Chemistry Major, Daegu University , Gyeongbuk 712-714, South Korea.
Lara K Abramowitz
Michelle R Bond
Dona C Love
Dong W Kang
Hans F Leucke
Dae W Kang
Jong-Seog Ahn
John A Hanover

Funding

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of DiseaseZIADK060101 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$25.7M
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegenerationZIADK060103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$20.8M
Calmodulin-driven Nuclear Trafficking linked to diabetes and insulin signalingZIADK060102 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$8.5M
Chemical Genetic Elucidation of Histone Acetyltransferase Signaling NetworksZIADK059703 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI LUECKE, HANS · 2009 to 2014
$2.9M
Intramural NIH HHS
6 · The paper itself

Abstract

The dynamic glycosylation of serine/threonine residues on nucleocytoplasmic proteins with a single N-acetylglucosamine (O-GlcNAcylation) is critical for many important cellular processes. Cellular O-GlcNAc levels are highly regulated by two enzymes: O-GlcNAc transferase (OGT) is responsible for GlcNAc addition and O-GlcNAcase (OGA) is responsible for removal of the sugar. The lack of a rapid and simple method for monitoring OGT activity has impeded the efficient discovery of potent OGT inhibitors. In this study we describe a novel, single-well OGT enzyme assay that utilizes 6 × His-tagged substrates, a chemoselective chemical reaction, and unpurified OGT. The high-throughput Ni-NTA Plate OGT Assay will facilitate discovery of potent OGT-specific inhibitors on versatile substrates and the characterization of new enzyme variants.

Indexed as

Enzyme Assaysbeta-N-AcetylhexosaminidasesDose-Response Relationship, DrugEnzyme InhibitorsHumansMolecular StructureN-AcetylglucosaminyltransferasesNickelOrganometallic CompoundsStructure-Activity RelationshipSubstrate Specificitybeta-N-AcetylhexosaminidasesEnzyme InhibitorsN-AcetylglucosaminyltransferasesNickelO-GlcNAc transferaseOrganometallic Compounds

Identifiers

PMID24866374
PMCPMC4215860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.